Skip to main content
Top

11-09-2024 | Obstructive Sleep Apnea | News

ERS 2024

Sulthiame shows potential as a drug treatment for OSA

Author: Lucy Piper

medwireNews: Research presented at the ERS Congress 2024 supports sulthiame 200 or 300 mg as a drug therapy for obstructive sleep apnea (OSA), showing it consistently reduces sleep disordered breathing and improves sleep quality.

Related topics

SPONSORED

Targeting COPD with type 2 inflammation: emerging biologic landscape

  • Live
  • Webinar | 03-12-2024 | 19:00 (CET)

LIVE: Tuesday, 3 December 2024, 19:00-20:30 (CET)

Join us for an insightful session tailored for pulmonologists and healthcare professionals eager to enhance their understanding of COPD and the latest advances in biologic therapies. 

Sponsored by:
  • Sanofi
Developed by: Springer Healthcare
Reserve your place

A quick guide to ECGs

Improve your ECG interpretation skills with this comprehensive, rapid, interactive course. Expert advice provides detailed feedback as you work through 50 ECGs covering the most common cardiac presentations to ensure your practice stays up to date. 

PD Dr. Carsten W. Israel
Developed by: Springer Medizin
Start the cases